$SRNE News Article - Levena Biopharma, A Sorrento
Post# of 74540
(Total Views: 85)
Posted On: 05/03/2022 2:15:56 PM
$SRNE News Article - Levena Biopharma, A Sorrento Company, Announces Positive Clinical Data for Its Out-Licensed A166 Product Candidate, A Third-Generation Anti-HER2-ADC, In Treating Heavily Pretreated HER2-Positive Breast Cancer Patients https://marketwirenews.com/news-releases/leve...20035.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼